Breast Cancer
Findings advance knowledge in breast cancer research
Published in Women's Health Weekly, April 10th, 2006
Study 1: Fluorouracil-epirubicin-navelbine (FEN) was deemed an effective first-line chemotherapy treatment for patients with advanced breast cancer (BC).
"A phase II study was carried out to determine the safety and efficacy of the combination of FEN as first-line chemotherapy in advanced breast cancer (BC). Thirty-four women with advanced BC, aged 32-75 years (median 59), previously untreated for recurrence, were enrolled in the study. The treatment consisted of fluorouracil 600 mg/m2 on day 1, epirubicin 75 mg/m2 on day 1 and vinorelbine 25...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer treatment disparities may exist due to ethnicity and insurance status - Colon Cancer
Colon cancer risk may be associated with central adiposity in women - Hypertension
Hypertension may be adversely affected by swimming therapy in older women - Ischemia
Myocardial perfusion is improved by tibolone therapy in women with ischemic heart disease - Obesity Research
Obesity risk in women may be related to socioeconomic status in childhood - Apoptosis
Estrogen induction protects cells from mediated apoptosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
